Tengonermin Antibody

Tengonermin (ARENEGYR) is a vascular-targeting agent composed of human TNF-α fused to the CNGRCG peptide. It modifies the tumor microenvironment to improve the delivery of chemotherapeutics and promote T-cell infiltration, facilitating research in oncology and immunotherapy in both in vitro and in vivo models.